Poster Abstracts

PresenterAbstract Title
Matthew BeyersTHE INTEGRATED CANINE DATA COMMONS: AN OPEN PUBLIC DATA SHARING PLATFORM
Barbara BorgesCELL CYCLE GENES AS POTENTIAL PROGNOSTIC BIOMARKERS IN CANINE MAMMARY CANCER
Jacqueline BowalPROGNOSTIC SIGNIFICANCE OF COMPLETE RESPONSE DURING RADIATION IN FELINE SINO-NASAL LYMPHOMA: A RETROSPECTIVE COHORT STUDY
Rachel BradyTHE IMPORTANCE OF IMMUNOHISTOCHEMISTRY IN THE DIAGNOSIS OF SUSPECTED NON-VISCERAL LEIOMYOSARCOMA
Graham BrownINTRATUMORAL TREATMENT OF CANINE HIGH-GRADE MAST CELL TUMORS WITH TIGILANOL TIGLATE (EBC-46).
Laura ChadseyTREATMENT OF INDOLENT CUTANEOUS T CELL LYMPHOMA (CUTANEOUS LYMPHOCYTOSIS) WITH HYPOFRACTIONATED RADIATION THERAPY IN THREE CATS
Jason ChibukOWNER ATTITUDES TOWARD SCREENING FOR EARLY CANCER DETECTION IN PET DOGS
Victoria CostaEXPLORING THE ASSOCIATION OF INTRATUMORAL IMMUNE CELL INFILTRATES WITH HISTOPATHOLOGIC GRADE IN CANINE MAST CELL TUMORS
Miguel de la VirgenPILOT STUDY TO EVALUATE EFFICAY AND TOXICITY FOR AN ADJUVANT DOSE- INTENSIFIED DOXORUBICIN PROTOCOL IN DOGS WITH HEMANGIOSARCOMA FOLLOWING SPLENECTOMY
Carlos Fonseca-AlvesRAPAMYCIN ANTI-TUMORAL EFFECT ON PRIMARY AND METASTATIC CANINE MAMMARY GLAND TUMOR CELLS IN VITRO
Yasuhiro FukuyamaUSE OF MODIFIED MOHS PASTE IN TWO CASES OF MULTICENTRIC SQUAMOUS CELL CARCINOMA IN SITU ASSOCIATED WITH PAPILLOMAVIRUS INFECTION
Molly GaspariniCLINICAL OUTCOME AND PATHOLOGY OF CANINE THYROID CARCINOSARCOMA (2006-2020)
Allison GedneyEVALUATION OF THE SAFETY AND EFFICACY OF CORIOLUS VERSICOLOR POLYSACCHAROPEPTIDE (I’M YUNITY®) ALONE OR IN COMBINATION WITH DOXORUBICIN FOR DOGS WITH SPLENIC HEMANGIOSARCOMA AND ITS ABILITY TO PROLONG SURVIVAL
Nicolette HarrisADMINISTRATION REGIMEN AND FEEDING PROGRAM EFFECTS ON PHARMACOKINETIC AND PHARMACODYNAMIC PROFILES OF AN ORAL SULFORAPHANE SOURCE IN BEAGLE DOGS
William HendricksDESIGN, ANALYTICAL VALIDATION, AND DIAGNOSTIC YIELD OF A NOVEL CANINE CANCER GENE SEQUENCING PANEL
Ryota IwasakiIDENTIFICATION OF SENTINEL LYMPH NODES USING CT LYMPHOGRAPHY IN DOGS WITH ORAL MALIGNANT MELANOMA
Kirsten JacksonANALYSIS OF CANINE MYELOID DERIVED SUPPRESSOR CELLS (MDSCS) UTILIZING FLUORESCENCE-ACTIVATED CELL SORTING, RNA PROTECTION MEDIUMS TO YIELD GOOD QUALITY RNA FOR SINGLE CELL ANALYSIS USING THE 10X GENOMICS PLATFORM
Caitlin JazwiakCLINICAL BIOMARKERS OF CANCER CACHEXIA IN CATS
Selvi JegatheesonRESPONSE TO RADIOACTIVE IODINE (I131) ADMINISTRATION IN DOGS WITH THYROID CARCINOMA
Se-hoon KimANTI-CANCER EFFECT OF FENBENDAZOLE BY INDUCING G2/M ARREST AND MITOTIC SLIPPAGE ON CANINE MELANOMA CELL LINES
Luis LembckePHARMACOKINETICS AND TOXICITY OF CANNADROPS™ COCONUT, A COMMERCIALLY AVAILABLE CBD OIL FORMULATION IN LABORATORY DOGS
Atsushi MaedaOUTCOMES OF DOGS WITH LOCALIZED BILE DUCT CARCINOMA FOLLOWING SURGERY: A RETROSPECTIVE STUDY OF SEVEN DOGS
Takuya MaruoTOXICITY EVALUATION OF ALTERNATE-DAY TREATMENT WITH TEYSUNO (TEGAFUR/GIMERACIL/OTERACIL) IN DOG WITH SOLID TUMOR
Glenna MauldinCLINICAL OUTCOME IN DOGS WITH APOCRINE GLAND ADENOCARCINOMA OF THE ANAL SAC TREATED WITH DIFFERING RADIOTHERAPY PROTOCOLS
Yuta NishiyamaRE-IRRADIATION AFTER HYPOFRACTIONATED RADIOTHERAPY FOR RECURRENT INTRANASAL TUMORS IN DOGS: A RETROSPECTIVE STUDY
Aki OhmiCLINICAL CHARACTERISTICS AND OUTCOMES OF LYMPHOMA WITH MOTT CELL DIFFERENTIATION IN MINIATURE DACHSHUNDS
Gerald PostSAFETY AND TOXICITY OF SMALL MOLECULE INHIBITORS IN DOGS WITH SPONTANEOUSLY OCCURRING MALIGNANCIES—THE USE OF REAL WORLD DATA
Alex PyuenPROGNOSTIC SIGNIFICANCE OF KI67, AGNOR, CKIT PCR, AND KIT IHC FOR COMPLETELY EXCISED LOW GRADE CANINE MAST CELL TUMORS
Rothman ReyesPILOT TRIAL OF DOSE-INTENSE COMBINATION CHOP CHEMOTHERAPY IN LABORATORY DOGS
Yoshikawa RyutaroINTRAPERITONEAL ADMINISTRATION OF SYNTHETIC MICRORNA-214 EXHIBITS TUMOR SUPPRESSION IN AN INTRAPERITONEAL DISSEMINATION MOUSE MODEL OF CANINE HEMANGIOSARCOMA
Jacob SiewertFELINE CUTANEOUS LYMPHOMA: A RETROSPECTIVE REVIEW OF PRESENTATION, DIAGNOSIS, AND RESPONSE TO TREATMENT
Aimee SoileauTHE EFFECT OF ARGINASE ON CANINE LYMPHOCYTE FUNCTION AND ITS MODULATION BY VINCRISTINE CHEMOTHERAPY IN DOGS WITH LYMPHOMA
Lucy TeddyCYCLICAL 10-DAY DOSING OF MELPHALAN FOR THE TREATMENT OF CANINE MULTIPLE MYELOMA
Sergioi VazquezCHARACTERIZATION OF TUMOR ASSOCIATED MACROPHAGES IN CANINE LYMPHOMAS
Yusuke WadaRESPONSE AND OUTCOME OF 15 DOGS TREATED WITH TOCERANIB PHOSPHATE WITH THE RECURRENT NASAL CARCINOMA AFTER RADIATION THERAPY
Sita WithersEFFECT OF STIMULATOR OF INTERFERON GENES (STING) SIGNALING IN CANINE AND HUMAN OSTEOSARCOMA ON CYTOKINE/CHEMOKINE EXPRESSION AFTER RADIATION EXPOSURE
Wakana YonejiCERTIFICATION OF HERITABILITY OF FAMILIAL GASTROINTESTINAL POLYPOSIS IN JACK RUSSELL TERRIER AND ITS CLINICAL SIGNS.
Debora Aparecide Pires de Campos Zuccari3D CELL CULTURE – ON TOP METHOD AS A RELIABLE PRECISION THERAPY MODEL IN CANINE MAMMARY TUMORS